Previous Article | Next Article ![]()
J. Virol., 02 1995, 764-772, Vol 69, No. 2
NB Ray, LC Ewalt and DL Lodmell
To determine whether rabies viruses replicate in macrophage or
macrophage-like cells, several human and murine macrophage-like cell lines,
as well as primary cultures of murine bone marrow macrophages, were
incubated with the Evelyn-Rokitnicki-Abelseth (ERA) virus and several
different street rabies viruses (SRV). ERA rabies virus replicated well in
human monocytic U937 and THP-1 cells and murine macrophage IC-21 cells, as
well as primary cultures of murine macrophages. Minimal replication was
detected in murine monocytic WEHI- 3BD- and PU5-1R cells, and ERA virus did
not replicate in murine monocytic P388D1 or J774A.1 cells. A tissue
culture-adapted SRV of bat origin also replicated in IC-21 and U937 cells.
Non-tissue culture- adapted SRV isolated from different animal species,
particularly bats, replicated minimally in U937, THP-1, IC-21 cells and
primary murine bone marrow macrophages. To determine whether rabies virus
replication is dependent upon the state of differentiation of the
macrophage-like cell, human promyelocytic HL-60 cells were differentiated
with 12-O- tetradecanoylphorbol-13-acetate (TPA). ERA rabies virus
replicated in the differentiated HL-60 cells but not in undifferentiated
HL-60 cells. Persistent infections were established in macrophage-like U937
cells with ERA rabies virus and SRV, and infectious SRV was isolated from
adherent bone marrow cells of mice that had been infected 96 days
previously. Virus harvested from persistently infected U937 cells and the
adherent bone marrow cells had specifically adapted to each cell. This
specificity was shown by the inability of the viruses to infect macrophages
other than U937 cells and primary bone marrow macrophages, respectively.
Virus titers of the persistently infected U937 cells fluctuated with
extended cell passage. After 30 passages, virus released from the cells had
lost virulence as shown by its inability to kill intracranially inoculated
mice. However, the avirulent virus released from the persistently infected
cells was more efficient in infecting and replicating in naive U937 cells
than the virus which was used to establish the persistent infection. These
results suggest that macrophages may serve as reservoirs of infection in
vivo, sequestering virus which may subsequently be activated from its
persistent state, resulting in clinical infection and death.
Copyright © 1995, American Society for Microbiology
Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|